Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Úriz, Miriam ^a   Sáez, Elena ^a   Prieto, Jesús ^a   Medina, Juan F ^a   Banales, Jesús M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BILE ACID; CALCIUM ION; COLCHICINE; DEHYDROCHOLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; SECRETIN; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID; AE2 ANION EXCHANGER; ANION TRANSPORT PROTEIN; ANTIPORTER; PROTEIN KINASE C; TAURINE; TAUROCHENODEOXYCHOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BILE DUCT; BILE FLOW; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROTUBULE ASSEMBLY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; ANIMAL; BILE; BILIARY CIRRHOSIS; BIOLOGICAL MODEL; CELL CULTURE; COMMON BILE DUCT CYST; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; MICROTUBULE; PATHOLOGY; POLYMERIZATION; WISTAR RAT;

ANIMALS; ANION TRANSPORT PROTEINS; ANTIPORTERS; BILE; CELLS, CULTURED; CHOLEDOCHAL CYST; DEHYDROCHOLIC ACID; GENE SILENCING; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MICROTUBULES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERIZATION; PROTEIN KINASE C; RATS; RATS, WISTAR; SECRETIN; TAURINE; TAUROCHENODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

EID: 83455221623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028717     Document Type: Article

References (37)

1. Banales JM, Prieto J, Medina JF, (2006) Cholangiocyte anion exchange and biliary bicarbonate excretion. World J Gastroenterol 12: 3496-3511.
2. Kanno N, LeSage G, Glaser S, Alpini G, (2001) Regulation of cholangiocyte bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol 281: G612-625.
3. Banales JM, Arenas F, Rodríguez-Ortigosa CM, Sáez E, Uriarte I, et al. (2006) Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger. Hepatology 43: 266-275.
4. Tietz PS, Marinelli RA, Chen XM, Huang B, Cohn J, et al. (2003) Agonist-induced coordinated trafficking of functionally related transport proteins for water and ions in cholangiocytes. J Biol Chem 278: 20413-20419.
5. Poupon R, (2010) Primary biliary cirrhosis: a 2010 update. J Hepatol 52: 745-758.
6. Beuers U, (2006) Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 3: 318-328.
7. European-Association-for-the-Study-of-the-Liver (2009) EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 51: 237-267.
8. Lindor K, (2007) Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med 357: 1524-1529.
9. Beuers U, Hohenester S, de Buy Wenniger LJ, Kremer AE, Jansen PL, et al. (2010) The biliary HCO3- umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 52: 1489-1496.
10. Hohenester S, de Buy Wenniger LM, Paulusma CC, van Vliet SJ, Jefferson DM, et al. (2011) A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology in press.
11. Prieto J, García N, Martí-Climent JM, Penuelas I, Richter JA, et al. (1999) Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology 117: 167-172.
12. Medina JF, Martinez-Anso E, Vázquez JJ, Prieto J, (1997) Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 25: 12-17.
13. Prieto J, Qian C, García N, Díez J, Medina JF, (1993) Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 105: 572-578.
14. Rodríguez-Ortigosa CM, Banales JM, Olivas I, Uriarte I, Marín JJG, et al. (2010) Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat. Hepatology 52: 667-677.
15. Roma MG, Marinelli RA, Rodríguez Garay EA, (1991) Biliary excretion of polyethylene glycol molecular weight 900. Evidence for a bile salt-stimulated vesicular transport mechanism. Biochem Pharmacol 42: 1775-1781.
16. Uriarte I, Banales JM, Sáez E, Arenas F, Oude Elferink RP, et al. (2010) Bicarbonate secretion of mouse cholangiocytes involves Na+-HCO3- cotransport in addition to Na+-independent Cl-/HCO3- exchange. Hepatology 51: 891-902.
17. Banales JM, Masyuk TV, Bogert PS, Huang BQ, Gradilone SA, et al. (2008) Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease. Am J Pathol 173: 1637-1646.
18. Banales JM, Masyuk TV, Gradilone SA, Masyuk AI, Medina JF, et al. (2009) The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). Hepatology 49: 160-174.
19. Soloway RD, Hofmann AF, Thomas PJ, Schoenfield LJ, Klein PD, (1973) Triketocholanoic (dehydrocholic) acid. Hepatic metabolism and effect on bile flow and biliary lipid secretion in man. J Clin Invest 52: 715-724.
20. Wimmer R, Hohenester S, Pusl T, Denk GU, Rust C, et al. (2008) Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKCá-/PKA-dependent mechanism in rat liver. Gut 57: 1448-1454.
21. Subbiah MT, Kuksis A, Mookerjea S, (1969) Secretion of bile salts by intact and isolated rat livers. Can J Biochem 47: 847-854.
22. Rembacz KP, Woudenberg J, Hoekstra M, Jonkers EZ, van den Heuvel FA, et al. (2010) Unconjugated bile salts shuttle through hepatocyte peroxisomes for taurine conjugation. Hepatology 52: 2167-2176.
23. Denk GU, Maitz S, Wimmer R, Rust C, Invernizzi P, et al. (2010) Conjugation is essential for the anticholestatic effect of norursodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. Hepatology 52: 1758-1768.
24. Ishizaki K, Imada T, Tsurufuji M, (2005) Hepatoprotective bile acid 'ursodeoxycholic acid (UDCA)' Property and difference as bile acids. Hepatol Res 33: 174-177.
25. Sakisaka S, Harada M, Gondo K, Yoshitake M, Tanikawa K, (1994) Tubulovesicular transport of horseradish peroxidase in isolated rat hepatocyte couplets: effects of low temperature, cytochalasin B and bile acids. Hepatology 20: 1015-1023.
26. Kurz AK, Graf D, Schmitt M, Vom Dahl S, Häussinger D, (2001) Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. Gastroenterology 121: 407-419.
27. Alpini G, Glaser S, Baiocchi L, Francis H, Xia X, et al. (2005) Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats. Hepatology 41: 1037-1045.
28. Mancinelli R, Franchitto A, Gaudio E, Onori P, Glaser S, et al. (2010) After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes. Am J Pathol 176: 1790-1800.
29. Marzioni M, Francis H, Benedetti A, Ueno Y, Fava G, et al. (2006) Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts. Am J Pathol 168: 398-409.
30. Nathanson MH, Burgstahler AD, Masyuk A, Larusso NF, (2001) Stimulation of ATP secretion in the liver by therapeutic bile acids. Biochem J 358: 1-5.
31. Fiorotto R, Spirlì C, Fabris L, Cadamuro M, Okolicsanyi L, et al. (2007) Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. Gastroenterology 133: 1603-1613.
32. Minagawa N, Nagata J, Shibao K, Masyuk AI, Gomes DA, et al. (2007) Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile. Gastroenterology 133: 1592-1602.
33. Invernizzi P, Setchell KDR, Crosignani A, Battezzati PM, Larghi A, et al. (1999) Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology 29: 320-327.
34. Setchell KDR, Rodrigues CMP, Podda M, Crosignani A, (1996) Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. Gut 38: 439-446.
35. Sturman JA, Hepner GW, Hofmann AF, Thomas PJ, (1975) Metabolism of [35S]taurine in man. J Nutr 105: 1206-1214.
36. Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, et al. (1990) Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology 98: 1044-1050.
37. Ito T, Schaffer SW, Azuma J, (2011) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids in press.